137 related articles for article (PubMed ID: 24420781)
21. Geostatistical modelling enables efficient safety assessment for mass drug administration with ivermectin in Loa loa endemic areas through a combined antibody and LoaScope testing strategy for elimination of onchocerciasis.
Johnson O; Giorgi E; Fronterrè C; Amoah B; Atsame J; Ella SN; Biamonte M; Ogoussan K; Hundley L; Gass K; Diggle PJ
PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010189. PubMed ID: 35139080
[TBL] [Abstract][Full Text] [Related]
22. Loa loa and Mansonella perstans microfilaremia in the department of Lékoumou, Republic of Congo.
Hemilembolo MC; Campillo JT; Niama AC; Pion SDS; Missamou F; Boussinesq M; Bileckot RR; Chesnais CB
Parasit Vectors; 2023 Dec; 16(1):451. PubMed ID: 38071391
[TBL] [Abstract][Full Text] [Related]
23. Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp.
Kamgno J; Boussinesq M; Labrousse F; Nkegoum B; Thylefors BI; Mackenzie CD
Am J Trop Med Hyg; 2008 Apr; 78(4):546-51. PubMed ID: 18385346
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of concomitant infections due to Loa loa, Mansonella perstans, and Onchocerca volvulus in rain forest villages of Cameroon.
Wanji S; Tendongfor N; Esum M; Ndindeng S; Enyong P
Med Microbiol Immunol; 2003 Feb; 192(1):15-21. PubMed ID: 12592559
[TBL] [Abstract][Full Text] [Related]
25. Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
Wanji S; Eyong EJ; Tendongfor N; Ngwa CJ; Esuka EN; Kengne-Ouafo AJ; Datchoua-Poutcheu FR; Enyong P; Agnew D; Eversole RR; Hopkins A; Mackenzie CD
PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005576. PubMed ID: 28686693
[TBL] [Abstract][Full Text] [Related]
26. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
Pion SD; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
Parasitology; 2006 Jul; 133(Pt 1):101-9. PubMed ID: 16764737
[TBL] [Abstract][Full Text] [Related]
27. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon.
Akue JP; Nkoghe D; Padilla C; Moussavou G; Moukana H; Mbou RA; Ollomo B; Leroy EM
PLoS Negl Trop Dis; 2011 Oct; 5(10):e1329. PubMed ID: 22022623
[TBL] [Abstract][Full Text] [Related]
29. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.
Bourguinat C; Kamgno J; Boussinesq M; Mackenzie CD; Prichard RK; Geary TG
Am J Trop Med Hyg; 2010 Jul; 83(1):28-32. PubMed ID: 20595473
[TBL] [Abstract][Full Text] [Related]
31. Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg).
Kamgno J; Pion SD; Tejiokem MC; Twum-Danso NA; Thylefors B; Boussinesq M
Trans R Soc Trop Med Hyg; 2007 Aug; 101(8):777-85. PubMed ID: 17531279
[TBL] [Abstract][Full Text] [Related]
32. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections.
Richard-Lenoble D; Kombila M; Rupp EA; Pappayliou ES; Gaxotte P; Nguiri C; Aziz MA
Am J Trop Med Hyg; 1988 Nov; 39(5):480-3. PubMed ID: 3195695
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and intensity of Loa loa infection over twenty-three years in three communities of the Mbalmayo health district (Central Cameroon).
Mogoung-Wafo AE; Nana-Djeunga HC; Domche A; Fossuo-Thotchum F; Bopda J; Mbickmen-Tchana S; Djomo-Kamga H; Kamgno J
BMC Infect Dis; 2019 Feb; 19(1):146. PubMed ID: 30760228
[TBL] [Abstract][Full Text] [Related]
34. Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis.
Boullé C; Chesnais CB; Kamgno J; Gardon J; Chippaux JP; Ranque S; Garcia A; Pion SD; Boussinesq M
Lancet Microbe; 2023 Feb; 4(2):e93-e101. PubMed ID: 36646105
[TBL] [Abstract][Full Text] [Related]
35. Integrated xenosurveillance of Loa loa, Wuchereria bancrofti, Mansonella perstans and Plasmodium falciparum using mosquito carcasses and faeces: A pilot study in Cameroon.
Pryce J; Pilotte N; Menze B; Sirois AR; Zulch M; Agbor JP; Williams SA; Wondji CS; Reimer L
PLoS Negl Trop Dis; 2022 Nov; 16(11):e0010868. PubMed ID: 36322515
[TBL] [Abstract][Full Text] [Related]
36. Influence of Mansonella perstans microfilaraemia on total IgE levels in Gabonese patients co-infected with Loa loa.
Bouyou-Akotet MK; Moussavou Boussougou MN; Ovono-Abessolo F; Owono-Medang M; Kombila M
Acta Trop; 2014 Mar; 131():11-5. PubMed ID: 24280145
[TBL] [Abstract][Full Text] [Related]
37. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon.
Kouam MK; Tchatchueng-Mbougua JB; Demanou M; Boussinesq M; Pion SD; Kamgno J
Parasit Vectors; 2013 Sep; 6(1):283. PubMed ID: 24289520
[TBL] [Abstract][Full Text] [Related]
38. Loa loa and Mansonella perstans infections in Ijebu north, western Nigeria: a parasitological study.
Agbolade M; Akinboye DO
Jpn J Infect Dis; 2001 Jun; 54(3):108-10. PubMed ID: 11544400
[TBL] [Abstract][Full Text] [Related]
39. [The efficacy and tolerance of ivermectin (Mectizan) prescribed for the patient with multiple filarial infections (Loa loa/Onchocerca and/or M. perstans)].
Richard-Lenoble D; Kombila M; Chandenier J; Gaxotte P
Bull Soc Pathol Exot Filiales; 1989 Jan; 82(1):65-71. PubMed ID: 2743519
[TBL] [Abstract][Full Text] [Related]
40. Case Report: Probable Case of Spontaneous Encephalopathy Due to Loiasis and Dramatic Reduction of
Arrey-Agbor DB; Nana-Djeunga HC; Mogoung-Wafo AE; Mafo M; Danwe C; Kamgno J
Am J Trop Med Hyg; 2018 Jul; 99(1):112-115. PubMed ID: 29741149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
